Empagliflozin had no clinically relevant effect on the pharmacokinetics of metformin, glimepiride, pioglitazone, sitagliptin, linagliptin, warfarin, digoxin, ramipril, simvastatin, hydrochlorothiazide, torsemide, and oral contraceptives when coadministered in healthy volunteers (see Figure 2)
Side effects are minimal, typically limited to mild injection site redness
Consistency matters more than anything
IMPORTANT NOTICE: This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use
Dry eye and light sensitivity Some stroke survivors have problems with blinking or not being able to fully close their eyes
Laboratory studies suggest that GLP-1 receptor agonists can protect neurons from damage caused by toxic protein aggregates, excitotoxicity, and metabolic stressprocesses implicated in neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease